Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo

Nathaniel H. Boyd, Kiera Walker, Joshua Fried, James R. Hackney, Paul C. McDonald, Gloria A. Benavides, Raffaella Spina, Alessandra Audia, Sarah E. Scott, Catherine J. Landis, Anh Nhat Tran, Mark O. Bevensee, Corinne Griguer, Susan Nozell, G. Yancey Gillespie, Burt Nabors, Krishna P. Bhat, Eli E. Bar, Victor Darley-Usmar, Bo Xu, Emily Gordon, Sara J. Cooper, Shoukat Dedhar, Anita B. Hjelmeland

Open source

DOI
10.1172/jci.insight.92928
Published
2017-12-21
Container
JCI Insight
Publisher
American Society for Clinical Investigation
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1172/jci.insight.92928,
  title = {Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo},
  author = {Nathaniel H. Boyd and Kiera Walker and Joshua Fried and James R. Hackney and Paul C. McDonald and Gloria A. Benavides and Raffaella Spina and Alessandra Audia and Sarah E. Scott and Catherine J. Landis and Anh Nhat Tran and Mark O. Bevensee and Corinne Griguer and Susan Nozell and G. Yancey Gillespie and Burt Nabors and Krishna P. Bhat and Eli E. Bar and Victor Darley-Usmar and Bo Xu and Emily Gordon and Sara J. Cooper and Shoukat Dedhar and Anita B. Hjelmeland},
  year = {2017},
  journal = {JCI Insight},
  doi = {10.1172/jci.insight.92928},
  url = {https://doi.org/10.1172/jci.insight.92928}
}

RIS

TY  - JOUR
TI  - Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo
AU  - Nathaniel H. Boyd
AU  - Kiera Walker
AU  - Joshua Fried
AU  - James R. Hackney
AU  - Paul C. McDonald
AU  - Gloria A. Benavides
AU  - Raffaella Spina
AU  - Alessandra Audia
AU  - Sarah E. Scott
AU  - Catherine J. Landis
AU  - Anh Nhat Tran
AU  - Mark O. Bevensee
AU  - Corinne Griguer
AU  - Susan Nozell
AU  - G. Yancey Gillespie
AU  - Burt Nabors
AU  - Krishna P. Bhat
AU  - Eli E. Bar
AU  - Victor Darley-Usmar
AU  - Bo Xu
AU  - Emily Gordon
AU  - Sara J. Cooper
AU  - Shoukat Dedhar
AU  - Anita B. Hjelmeland
PY  - 2017
JO  - JCI Insight
DO  - 10.1172/jci.insight.92928
UR  - https://doi.org/10.1172/jci.insight.92928
ER  - 

APA

Boyd, N. H., Walker, K., Fried, J., Hackney, J. R., McDonald, P. C., Benavides, G. A., Spina, R., Audia, A., Scott, S. E., Landis, C. J., Tran, A. N., Bevensee, M. O., Griguer, C., Nozell, S., Gillespie, G. Y., Nabors, B., Bhat, K. P., Bar, E. E., Darley-Usmar, V., Xu, B., Gordon, E., Cooper, S. J., Dedhar, S., & Hjelmeland, A. B. (2017). Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo. JCI Insight. https://doi.org/10.1172/jci.insight.92928

Source records